Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and …
Objectives To synthesise evidence on incidence rates and risk factors for myocarditis and
pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term …
pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term …
Death after the administration of COVID-19 vaccines approved by EMA: has a causal relationship been demonstrated?
More than eight billion doses of COVID-19 vaccines have been administered globally so far
and 44.29% of people are fully vaccinated. Pre-authorization clinical trials were carried out …
and 44.29% of people are fully vaccinated. Pre-authorization clinical trials were carried out …
[HTML][HTML] Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis? Review of the current evidence, insights, and future directions
AS Ulucay, G Singh, SH Kanuri - Indian Heart Journal, 2023 - Elsevier
According to recent epidemiological analysis, the percentage of world population infected
with COVID-19 by end of December 2020 is approximately 12.56% 1. COVID induced acute …
with COVID-19 by end of December 2020 is approximately 12.56% 1. COVID induced acute …
[HTML][HTML] mRNA-based COVID-19 vaccines booster dose: benefits, risks, and coverage
The number of COVID-19 vaccine-rich countries that have started COVID-19 third-dose
booster programs is growing dramatically despite the lack of robust evidence on the …
booster programs is growing dramatically despite the lack of robust evidence on the …
Case report: Myocarditis following COVID-19 protein subunit vaccination
Y Dong, X Liu, C Yang, Q Qi, W Shi, Y Li… - Frontiers in …, 2022 - frontiersin.org
We report findings in a 34-year-old female patient who presented with fulminant myocarditis
8 days after receiving the first dose of the ZF2001 RBD-subunit vaccine against coronavirus …
8 days after receiving the first dose of the ZF2001 RBD-subunit vaccine against coronavirus …
Is there a causal link between acute myocarditis and COVID-19 vaccination: an umbrella review of published systematic reviews and meta-analyses
A Bouchlarhem, S Boulouiz, Z Bazid… - Clinical Medicine …, 2024 - journals.sagepub.com
Introduction: A few months after the beginning of the coronavirus disease of 2019 (COVID-
19) vaccination, several reports of myocarditis secondary to the vaccines were published …
19) vaccination, several reports of myocarditis secondary to the vaccines were published …
Myopericarditis in a male adolescent following the second shot of COVID-19 pfizer m-RNA vaccine: Typical example and analysis of 110 single case reports
A Piras, G Melis, L Cugusi, PP Bassareo - Pediatric Reports, 2022 - mdpi.com
One of the most powerful weapons against COVID-19 is vaccines. After the worldwide
spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also …
spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also …
mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation
C Fenton, A Lee - Drugs & Therapy Perspectives, 2022 - Springer
Abstract mRNA vaccines are considered to be important tools for the management of the
COVID-19 pandemic. Although mRNA COVID-19 vaccines are well tolerated in most …
COVID-19 pandemic. Although mRNA COVID-19 vaccines are well tolerated in most …
Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology
The COVID-19 pandemic has led to significant loss of life and severe disability, justifying the
expedited testing and approval of messenger RNA (mRNA) vaccines. While found to be safe …
expedited testing and approval of messenger RNA (mRNA) vaccines. While found to be safe …
[HTML][HTML] Covaxin-induced lymphocytic myocarditis
N Mittal, D Pawar, K Parmar, Z Sly, G Del Rio-Pertuz… - Cureus, 2022 - ncbi.nlm.nih.gov
We report the case of a young adult male with endomyocardial biopsy-proven lymphocytic
myocarditis following Covaxin administration. Covaxin differs from the mRNA vaccines in …
myocarditis following Covaxin administration. Covaxin differs from the mRNA vaccines in …